As at March 15, 2017
13,473,063 |
| | Common Shares issued and outstanding | ? |
| | Preferred Shares issued and outstanding
| 3,779,245
|
| | Common Shares issuable upon exercise of outstanding warrants | 968,264 |
| | Stock Options outstanding | 567,665
|
| | Additional Common Shares available for future grants under our stock option plan
|
http://secfilings.nasdaq.com/...0INC.&FormType=20-F&View=html
| | Number of equivalent shares
|
| Weighted average exercise price
|
|
|
| | | |
| ($) |
| | | October 2012 Investor Warrants | | 29,675 |
| 345.00 |
| | | July 2013 Warrants | | 25,996 |
| 185.00 |
| | | March 2015 Series A Warrants (e) | | 447,574 |
| 2.83 |
| | | December 2015 Warrants | | 2,331,000 |
| 7.10 |
| | | November 2016 Warrants (f) | | 945,000
|
| 4.70 |
| |
|
3779245 Warrants
of all warrants outstanding as at March 31, 2017
Outstanding Share Data
As at May 8, 2017 , we had 14,333,659 million common shares issued and outstanding, as well as 967,905 stock options outstanding. Share purchase warrants outstanding as at May 8, 2017 represented a total of 3,779,245 equivalent common shares.
http://secfilings.nasdaq.com/...20INC.&FormType=6-K&View=html
|